drugset / Trial / NCT04274114

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine

NCT04274114

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this randomized clinical trial is to examine the efficacy of L-glutamine for the treatment of generalized anxiety disorder compared versus placebo.

Timeline

Start
2019-01-18
Primary completion
2020-05-12
Completion
2020-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 5 g
Subject Glutamine Other / unclassified 25 g